Patents by Inventor Alain Bayol

Alain Bayol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
    Patent number: 5811096
    Abstract: The invention relates to a physically stable, pharmaceutically acceptable liquid composition containing urate oxidase, and from 0.1 mg/ml to 10 mg/ml of Poloxamer 188, in buffered aqueous medium. This composition can be obtained by dissolving a lyophilibate in an aqueous solvent.
    Type: Grant
    Filed: May 10, 1996
    Date of Patent: September 22, 1998
    Assignee: Sanofi
    Inventors: Claude Aleman, Alain Bayol, Thierry Breul, Patrice Dupin
  • Stable freeze-dried formulation comprising a protein assay kit
    Patent number: 5763409
    Abstract: A stable, freeze-dried, and pharmaceutically acceptable formulation includes a protein, a buffer, alanine, and mannitol, at a mass ratio of mannitol/alanine being 0.1-1, wherein the formulation being useful in an assay kit.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: June 9, 1998
    Assignee: Sanofi
    Inventors: Alain Bayol, Thierry Breul, Patrice Dupin, Philippe Faure
  • Drugs containing a glycosylated interleukin-2
    Patent number: 5417970
    Abstract: An interleukin-2 preparation suitable for pharmaceutical purposes, consisting essentially of disialilated glycosylated interleukin-2, monosialilated glycosylated interleukin-2, or a mixture thereof, and substantially free of organic solvents, is isolated from recombinant CHO cells transformed with a vector containing a DNA sequence coding for a natural precursor of human interleukin-2, and is purified by a multi-step process.
    Type: Grant
    Filed: November 16, 1993
    Date of Patent: May 23, 1995
    Assignee: Sanofi
    Inventors: Willem Roskam, deceased, Bertrand Basuyaux, Pascual Ferrara, Martine Laporte, Thierry Maureaud, Natalio Vita, Alain Bayol, Genevieve Perry
  • Xylan sulfates of low molecular weight, process for their preparation and medicaments containing them
    Patent number: 4713373
    Abstract: The present invention relates to novel xylan sulfates of average molecular weight comprised between 2000 and 5000 Daltons.The invention also relates to their process of preparation by fractionation and their use in therapeutics as orally active antithrombotic and hypolipaemic agents.
    Type: Grant
    Filed: October 31, 1985
    Date of Patent: December 15, 1987
    Assignee: Sanofi S.A.
    Inventors: Alain Bayol, Francis Blanc, Jacqueline Lansen, Jean-Pierre Maffrand, Jean-Marie Pereillo
  • Xylane sulfates, process for their preparation, and anti-thrombosis and hypolipemic activity thereof
    Patent number: 4699900
    Abstract: This invention relates to new xylane sulfates having an apparent molar weight comprised between 7000 and 12000.This invention relates also to a process for their preparation by fractionation, and to the therapeutic application thereof as anti-thrombosis and hypolipemic agents.
    Type: Grant
    Filed: March 23, 1984
    Date of Patent: October 13, 1987
    Assignee: Sanofi S.A.
    Inventors: Alain Bayol, Jacqueline Lansen, Jean P. Maffrand, Jean-Marie Pereillo, Eric Vallee